Literature DB >> 27815857

Cerebellar Assessment in Early Multiple Sclerosis.

Amandine Moroso1,2,3, Aurélie Ruet1,2,3, Mathilde Deloire1, Delphine Lamargue-Hamel2,3, Stéphanie Cubizolle1, Julie Charré-Morin1, Aurore Saubusse1, Bruno Brochet4,5,6.   

Abstract

Cerebellar impairment is frequent and predictive of disability in multiple sclerosis (MS). The Nine-Hole Peg Test (NHPT) is commonly used to assess cerebellar symptoms despite its lack of specificity for cerebellar ataxia. Eye-tracking is a reliable test for identifying subtle cerebellar symptoms and could be used in clinical trials, including those involving early MS patients. To evaluate, by the use of eye-tracking, the accuracy of the NHPT in detecting subtle cerebellar symptoms in patients with clinically isolated syndrome with a high risk of conversion to MS (HR-CIS). Twenty-nine patients and 13 matched healthy controls (HC) underwent an eye-tracking protocol. Cerebellar impairment was defined by registration of saccadic intrusions or at least 10 % dysmetria in a saccadic movement recording. These criteria were compared to NHPT performance. Sixteen patients fulfilled saccadic criteria for cerebellar impairment. NHPT performance was significantly increased in HR-CIS patients (p < 0.01) versus HC. However, NHPT performance did not differ between cerebellar and non-cerebellar groups. NHPT performance with the dominant hand could differentiate patients, particularly cerebellar patients, from HC, but it could not discriminate cerebellar from non-cerebellar patients who were classified according to saccadic criteria. These findings should be considered in future clinical trials involving HR-CIS patients.

Entities:  

Keywords:  Cerebellum; Eye movements; Multiple sclerosis; Nine-hole peg test

Mesh:

Year:  2017        PMID: 27815857     DOI: 10.1007/s12311-016-0831-8

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  13 in total

Review 1.  Using saccades as a research tool in the clinical neurosciences.

Authors:  R J Leigh; Christopher Kennard
Journal:  Brain       Date:  2003-11-07       Impact factor: 13.501

2.  Adult norms for a commercially available Nine Hole Peg Test for finger dexterity.

Authors:  Kimatha Oxford Grice; Kimberly A Vogel; Viet Le; Ana Mitchell; Sonia Muniz; Mary Ann Vollmer
Journal:  Am J Occup Ther       Date:  2003 Sep-Oct

3.  The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome.

Authors:  B G Weinshenker; G P Rice; J H Noseworthy; W Carriere; J Baskerville; G C Ebers
Journal:  Brain       Date:  1991-04       Impact factor: 13.501

4.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure.

Authors:  G R Cutter; M L Baier; R A Rudick; D L Cookfair; J S Fischer; J Petkau; K Syndulko; B G Weinshenker; J P Antel; C Confavreux; G W Ellison; F Lublin; A E Miller; S M Rao; S Reingold; A Thompson; E Willoughby
Journal:  Brain       Date:  1999-05       Impact factor: 13.501

5.  Regional grey matter atrophy in clinically isolated syndromes at presentation.

Authors:  R G Henry; M Shieh; D T Okuda; A Evangelista; M L Gorno-Tempini; D Pelletier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-09       Impact factor: 10.154

6.  Composite cerebellar functional severity score: validation of a quantitative score of cerebellar impairment.

Authors:  Sophie Tezenas du Montcel; Perrine Charles; Pascale Ribai; Cyril Goizet; Alice Le Bayon; Pierre Labauge; Lucie Guyant-Maréchal; Sylvie Forlani; Celine Jauffret; Nadia Vandenberghe; Karine N'guyen; Isabelle Le Ber; David Devos; Carlo-Maria Vincitorio; Mario-Ubaldo Manto; François Tison; Didier Hannequin; Merle Ruberg; Alexis Brice; Alexandra Durr
Journal:  Brain       Date:  2008-03-31       Impact factor: 13.501

7.  MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.

Authors:  V M Anderson; L K Fisniku; D R Altmann; A J Thompson; D H Miller
Journal:  Mult Scler       Date:  2009-05-22       Impact factor: 6.312

8.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

Authors:  L Kappos; C H Polman; M S Freedman; G Edan; H P Hartung; D H Miller; X Montalban; F Barkhof; L Bauer; P Jakobs; C Pohl; R Sandbrink
Journal:  Neurology       Date:  2006-08-16       Impact factor: 9.910

9.  A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis.

Authors:  V M Anderson; C A M Wheeler-Kingshott; K Abdel-Aziz; D H Miller; A Toosy; A J Thompson; O Ciccarelli
Journal:  Mult Scler       Date:  2011-04-20       Impact factor: 6.312

10.  Defining the clinical course of multiple sclerosis: the 2013 revisions.

Authors:  Fred D Lublin; Stephen C Reingold; Jeffrey A Cohen; Gary R Cutter; Per Soelberg Sørensen; Alan J Thompson; Jerry S Wolinsky; Laura J Balcer; Brenda Banwell; Frederik Barkhof; Bruce Bebo; Peter A Calabresi; Michel Clanet; Giancarlo Comi; Robert J Fox; Mark S Freedman; Andrew D Goodman; Matilde Inglese; Ludwig Kappos; Bernd C Kieseier; John A Lincoln; Catherine Lubetzki; Aaron E Miller; Xavier Montalban; Paul W O'Connor; John Petkau; Carlo Pozzilli; Richard A Rudick; Maria Pia Sormani; Olaf Stüve; Emmanuelle Waubant; Chris H Polman
Journal:  Neurology       Date:  2014-05-28       Impact factor: 9.910

View more
  3 in total

1.  Impairments in Walking Ability, Dexterity, and Cognitive Function in Multiple Sclerosis Are Associated with Different Regional Cerebellar Gray Matter Loss.

Authors:  Matthias Grothe; Martin Lotze; Sönke Langner; Alexander Dressel
Journal:  Cerebellum       Date:  2017-12       Impact factor: 3.847

Review 2.  Cerebellar Dysfunction in Multiple Sclerosis.

Authors:  Alastair Wilkins
Journal:  Front Neurol       Date:  2017-06-28       Impact factor: 4.003

Review 3.  Leveraging Visual Outcome Measures to Advance Therapy Development in Neuroimmunologic Disorders.

Authors:  Jennifer S Graves; Frederike Cosima Oertel; Anneke Van der Walt; Sara Collorone; Elias S Sotirchos; Gorm Pihl-Jensen; Philipp Albrecht; E Ann Yeh; Shiv Saidha; Jette Frederiksen; Scott Douglas Newsome; Friedemann Paul
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-12-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.